German Digital Health Study Tests App Activation Strategies for Ankylosing Spondylitis Management — Implications for Australian Digital Therapeutics

References

1. 1.Australian Government Department of Health. (2023). Software as Medical Device: Guidance for Industry. Therapeutic Goods Administration. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-guidance-industry
2. 2.Najm, A., Nikiphorou, E., Kostine, M., Goupille, P., Richette, P., Baraliakos, X., ... & Berenbaum, F. (2023). Digital health and artificial intelligence in rheumatic musculoskeletal diseases. Nature Reviews Rheumatology, 19(9), 585-601. https://doi.org/10.1038/s41584-023-00985-2
3. 3.Sieper, J., & Poddubnyy, D. (2023). Axial spondyloarthritis. The Lancet, 401(10379), 747-761. https://doi.org/10.1016/S0140-6736(23)00048-X
4. 4.Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., ... & Haroon, N. (2019). 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis & Rheumatology, 71(10), 1599-1613. https://doi.org/10.1002/art.40675
5. 5.Wuerzburg University Hospital. (2024). Real-world Quality Management Study With Axia to Evaluate the Measures of the DigiG (RAEMD Study). ClinicalTrials.gov. NCT07561255. https://clinicaltrials.gov/study/NCT07561255